TenX Keane extends SPAC deadline to July 18 with $66,667 Citius Pharma deposit

CITIUS ONCOLOGY, INC.

Citius Pharma deposited $66,667 into TenX Keane trust account to extend business combination timeline from June 18 to July 18, 2024.
TenX issued $66,667 unsecured promissory note to Citius Pharma, no interest, repayable upon business combination close.
This is the third of up to seven allowed monthly extensions; prior deposits on April 26 and May 17, 2024.
Extension supports pending Merger Agreement to acquire Citius Oncology; repayment condition tied to trust account balance ≥$2M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.